Drug Database
TR

travoprost + timolol (TTFC, Alcon / TTFC, Alcon)

✓ Approved

Novartis AG · ADRB1 · 小分子

什么是 travoprost + timolol?

travoprost + timolol 是一种小分子,由Novartis AG研发。该药已获批,用于治疗相关适应症,给药途径:Others。

药物档案

商品名TTFC, Alcon, TTFC, Alcon
公司Novartis AG
药物类别小分子
分子靶点ADRB1, ADRB2, PTGFR
给药途径Others
状态Approved

作用机制

分子靶点

travoprost + timolol 作用于 3 个分子靶点:

ADRB1adrenoceptor beta 1 (B1AR, RHR)
ADRB2adrenoceptor beta 2 (ADRBR, B2AR)
PTGFRprostaglandin F receptor (FP)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

travoprost + timolol 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Eye disordersGlaucoma✓ Approved

相关研究文献

PubMedExpert opinion on drug safety2026-11-18

Ocular hyperemia with netarsudil/latanoprost fixed combination in glaucoma: an exploratory association analysis of tolerability outcomes by prior topical therapy and baseline ocular hyperemia.

Holló Gábor G

This post hoc analysis of MERCURY-3 evaluates factors associated with baseline ocular hyperemia and tolerability outcomes with netarsudil/latanoprost fixed combination (NET/LAT). MERCURY-3 was a prospective, randomized, double-masked, multicenter, Phase 3, European trial. Adults with open-angle glaucoma or ocular hypertension inadequately controlled on topical therapy were randomized to once-daily NET/LAT (n = 218) or bimatoprost/timolol fixed combination (BIM/TIM; n = 212) for 6 months. Patients were stratified by baseline ocular hyperemia status (none vs any grade) and associations with prior treatment, adverse events (AEs), and hyperemia evolution evaluated. In the NET/LAT arm, prior combination therapy was associated with a greater prevalence of baseline ocular hyperemia than prior monotherapy (distribution: p = 0.003). Patients with baseline hyperemia experienced higher rates of AEs (85% vs 63%), ocular treatment-related AEs (74% vs 39%), and conjunctival hyperemia (45% vs 26%) during treatment. Ocular hyperemia remained predominantly mild throughout follow-up, with a more stable severity trajectory linked to prior monotherapy compared with prior combination therapy. No comparable associations were observed with BIM/TIM. Prior treatment complexity and baseline ocular hyperemia status are associated with tolerability outcomes during NET/LAT therapy. These exploratory findings suggest that earlier step-up after monotherapy could be associated with more favorable tolerability. CT.gov identifier: NCT03284853.

PMID 43046532
阅读全文 →
PubMedInternational medical case reports journal2026-11-17

Management of Ahmed Glaucoma Valve Plate Exposure by Plate Removal and Tube Retention: A Case Report.

Alhemyari Mohammed S MS, Al-Hamdi Ibrahim Mohammed IM, Alhemyari Khalid K, Bamashmus Mahfouth A MA

Ahmed glaucoma valve (AGV) implantation is an established option for refractory glaucoma, including neovascular glaucoma (NVG). Exposure of glaucoma drainage device hardware is a serious complication because it increases the risk of infection and may require surgical repair or explantation. A 66-year-old man with diabetes, hypertension, and NVG secondary to diabetic retinopathy developed AGV plate exposure in the right eye two months after implantation. The exposed plate was removed while the tube was retained. The distal open end of the retained tube was positioned subconjunctivally approximately 8 mm posterior to the limbus beneath conjunctival/Tenon tissue. The tube was fixed to the sclera with 10-0 nylon, temporarily ligated with 7-0 Vicryl, and three fenestrations were created proximal to the ligature. Two weeks later, conjunctival wound dehiscence with tube exposure occurred and was repaired with an approximately 4 × 2 mm preserved scleral patch graft. At eight months after the final repair, the eye was quiet, the tube remained covered, and IOP was 14 mmHg while the patient was using dorzolamide-timolol. Tube function was not objectively confirmed. This case suggests that removal of an exposed Ahmed glaucoma valve (AGV) plate with retention of the tube may preserve a potential aqueous drainage pathway. However, subsequent conjunctival wound dehiscence and tube exposure required repair with a preserved scleral patch graft, highlighting the importance of adequate tube coverage, particularly in eyes with compromised conjunctiva. Following repair, tube coverage remained intact and intraocular pressure remained stable during eight months of follow-up, although the independent contribution of the retained tube to IOP control could not be confirmed. Longer follow-up and additional cases are needed to establish the efficacy and safety of this individualized approach.

PMID 43041822
阅读全文 →
PubMedInternational journal of surgery case reports2026-11-10

Polypseudophakia with the J&J synergy lens in high myopia: case report.

Durgan David D, Collins Noah N, Kim Jessica J, Hwang Frank F

As clinicians strive to provide personalized recommendations for patients, polypseudophakia may be an option for those outside the range of traditional extended depth-of-focus lenses. We describe a case with initial refractive success but the development of a potentially vision-threatening complication. A 40-year-old Asian man with high myopia presented for a refractive surgery consultation with a goal of total spectacle independence and underwent bilateral refractive lens exchange with the J&J Synergy lens in the capsular bag, and a minus-power Alcon MA60MA lens in the sulcus. Initially, there was refractive success with post-operative uncorrected distance vision of 20/20 in the right eye and 20/25 in the left eye at 6 months. However, both eyes developed transillumination defects with pigment in the anterior chamber, consistent with Uveitis-Glaucoma-Hyphema (UGH) syndrome. The patient ultimately elected bilateral explantation of the sulcus intraocular lenses (IOLs) due to this complication. To our knowledge, this is the first case using the J&J Synergy lens in polypseudophakia and the second to correct for high myopia. Surgical techniques for those with high myopia and thin corneas are rare, and this technique initially provided a hopeful refractive outlook. However, loss of the refractive target and the development of UGH syndrome challenged the safety of this technique. Further studies are needed to determine which patients can tolerate this procedure. Providers should proceed cautiously and anticipate complications such as UGH syndrome following secondary sulcus IOL placement.

PMID 43006000
阅读全文 →
PubMedJournal of cataract and refractive surgery2026-11-10

Effects of Ultrasound Modality, Viscosurgical Devices, and Automated Energy Modulation on Intraocular Thermal Exposure During Phacoemulsification.

Suzuki Hisaharu H

To characterize determinants of intraocular thermal exposure during phacoemulsification-ultrasound modality, ophthalmic viscosurgical device (OVD) use, and delivered ultrasound energy-and to evaluate whether automated energy modulation (Thermal Sentry) reduces anterior chamber and corneal incision temperature. Masked for review. Controlled ex vivo laboratory investigation using a porcine eye model. Continuous phacoemulsification was performed for 90 seconds using the UNITY Vitreoretinal Cataract System (UNITY VCS; Alcon Vision LLC, Fort Worth, TX, USA) in 80 enucleated porcine eyes under standardized settings (intraocular pressure 37 mmHg, vacuum limit 50 mmHg, aspiration flow rate 18 cc/min, ultrasound power 100%). Anterior chamber and incision temperatures were compared across three modalities (4D, torsional, longitudinal) with Thermal Sentry ON or OFF (n = 10/group), and under OVD-assisted 4D-mode conditions with Thermal Sentry ON or OFF (n = 10/group). Delivered energy (Joules) and cumulative dissipated energy (CDE) were recorded. Thermal exposure differed significantly among modalities (Thermal Sentry OFF), with longitudinal ultrasound producing the greatest elevation and 4D mode the smallest (all P < 0.001). OVD use increased thermal exposure during 4D-mode phacoemulsification. Temperature elevation correlated strongly with Joules (r = 0.857) and CDE (r = 0.860, both P < 0.001). Thermal Sentry reduced anterior chamber temperature elevation across all modalities and OVD conditions, and reduced incision temperature during torsional and longitudinal ultrasound, through reductions in delivered energy. Intraocular thermal exposure during phacoemulsification is influenced by ultrasound modality and OVD use and is closely associated with cumulative delivered energy. Automated ultrasound energy modulation is an effective strategy for limiting thermal exposure across the conditions tested.

PMID 43004921
阅读全文 →
PubMedCureus2026-11-08

Refractive and Visual Outcomes of Myopic Laser-Assisted In Situ Keratomileusis (LASIK) Centered on the Entrance Pupil Versus 50% of the Pupil-to-Vertex Chord.

Zhe Josh J, Molleti Sanjana S, Pawlowski Hanna H, Luu Teasha T et al.

Background Laser ablation in myopic laser-assisted in situ keratomileusis (LASIK) is most commonly centered on the entrance pupil, yet the pupil center sits temporal to the visual axis, making the corneal vertex a rational alternative. Comparative studies of the two landmarks have produced conflicting results, and although modern platforms allow the ablation to be placed at any fraction of the distance between them, to the best of our knowledge, no study has compared pupil centration against a 50% offset toward the vertex in myopic eyes. This study compared refractive accuracy, astigmatic outcomes, and the efficacy and safety indices of myopic LASIK centered on the entrance pupil versus 50% of the pupil-to-vertex chord. Methods This retrospective cohort study included 389 eyes of 211 patients undergoing primary myopic LASIK by a single surgeon with the WaveLight EX500 excimer laser (Alcon Laboratories Inc., Fort Worth, Texas, USA); 192 eyes centered on the entrance pupil; and 197 eyes treated at 50% of the pupil-to-vertex chord (chord mu). Refractive accuracy, residual astigmatism, Alpins vector indices, and efficacy and safety indices were compared at three months using generalized estimating equations clustered on the patient and adjusted for age, sex, and corneal astigmatism. Results Mean chord mu was 210 ± 109 µm and did not differ between groups. No endpoint favored either strategy: 182/192 (94.8%) versus 183/197 (92.9%) of eyes were within ±0.50 D of target (P = 0.56), residual astigmatism was 0.30 D in both groups (P = 0.27), the efficacy index was 1.00 ± 0.15 versus 0.99 ± 0.16 (P = 0.72), the safety index was 1.05 ± 0.13 in both groups (P = 0.95), and no eye lost two or more lines of corrected acuity. Group differences did not vary with chord mu. Conclusions In myopic LASIK, no statistically significant differences in refractive or high-contrast visual outcomes were detected between ablation centered on the entrance pupil and ablation centered halfway toward the corneal vertex. The study was not designed as an equivalence trial, and contrast sensitivity, night vision, and aberrometric outcomes were not assessed, so these findings indicate an absence of detected differences rather than established equivalence.

PMID 42997780
阅读全文 →
PubMedCirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica2026-11-06

Topical timolol in the treatment of pediatric pyogenic granuloma: A 23-case series.

Sánchez Pulido L J LJ, Vega Mata N N, Enríquez Zarabozo E M EM, Granell Suárez C C et al.

Pyogenic granuloma (PG) is a common benign vascular lesion in pediatric patients, characterized by rapid growth and a tendency to bleed. Surgical excision allows immediate resolution and histological confirmation, with low recurrence when including the base of the lesion, although it may require anesthesia and leave a scar. Topical timolol has emerged as a conservative alternative in selected patients. To evaluate the efficacy and safety of topical timolol 0.5% in the treatment of PG in pediatric patients. Retrospective case series of 23 pediatric patients (4 months-13 years) diagnosed with PG and treated between 2018 and 2024 with a 0.5% timolol formulation applied topically over the lesion as an off-label use. Demographic and clinical variables, treatment duration, final response, need for surgery, recurrence, and documented adverse events were analyzed. Ten patients (43.5%) achieved complete or near-complete resolution of the lesion, 6 (26.1%) showed a partial response at the end of treatment or prior to surgery, 5 (21.7%) did not respond or exhibited progression, and 2 (8.7%) were still receiving treatment at data cutoff. Twelve patients completed treatment without surgery; at cutoff, 14 (60.9%) had not undergone surgery, including the 2 cases still under treatment. Nine patients (39.1%) required surgery. No recurrences were documented among patients with complete or near-complete resolution during available follow-up, and no adverse events attributable to treatment were recorded. Topical timolol 0.5% can be considered an initial conservative alternative in selected pediatric patients, especially when avoiding or deferring surgery or anesthesia is desired. Surgery remains a definitive option, offering immediate resolution and the possibility of histological confirmation. Prospective comparative studies are needed to define more precisely the role of timolol compared to surgical treatment.

PMID 42992436
阅读全文 →

注册免费账户还可查看另外 7372 篇文献

免费注册查看全部文献 →

了解更多travoprost + timolol